Medexus Pharmaceuticals (MDP) News Today C$2.43 +0.05 (+2.10%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Medexus Pharmaceuticals (MDP) Set to Announce Earnings on ThursdayMedexus Pharmaceuticals (TSE:MDP) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports.October 31 at 9:37 AM | marketbeat.comMedexus Pharmaceuticals (TSE:MDP) Trading Up 1.6% - Should You Buy?Medexus Pharmaceuticals (TSE:MDP) Trading 1.6% Higher - Here's WhyOctober 24, 2024 | marketbeat.comAnalysts Issue Forecasts for Medexus Pharmaceuticals Inc.'s Q2 2025 Earnings (TSE:MDP)Medexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Analysts at Leede Financial issued their Q2 2025 earnings estimates for shares of Medexus Pharmaceuticals in a research note issued to investors on Monday, September 30th. Leede Financial analyst D. Loe forecasts that the company will post eaOctober 2, 2024 | marketbeat.comLeede Financial Reiterates "C$8.25" Price Target for Medexus Pharmaceuticals (TSE:MDP)Leede Financial set a C$8.25 price objective on shares of Medexus Pharmaceuticals and gave the company a "speculative buy" rating in a research note on Monday.September 30, 2024 | marketbeat.comVentum Cap Mkts Equities Analysts Reduce Earnings Estimates for Medexus Pharmaceuticals Inc. (TSE:MDP)Medexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Ventum Cap Mkts lowered their FY2025 earnings per share estimates for Medexus Pharmaceuticals in a research note issued on Monday, September 16th. Ventum Cap Mkts analyst S. Quenneville now expects that the company will earn $0.24 per share fSeptember 19, 2024 | marketbeat.comFDA extends review period for Medexus' treosulfan to 2025September 16, 2024 | msn.comMedexus Pharmaceuticals (TSE:MDP) Stock Price Down 19.4%Medexus Pharmaceuticals (TSE:MDP) Trading Down 19.4%September 16, 2024 | marketbeat.comMedexus Pharmaceuticals (TSE:MDP) Shares Up 6.6%Medexus Pharmaceuticals (TSE:MDP) Trading Up 6.6%September 5, 2024 | marketbeat.comSome May Be Optimistic About Medexus Pharmaceuticals' (TSE:MDP) EarningsAugust 20, 2024 | finance.yahoo.comQ3 2025 EPS Estimates for Medexus Pharmaceuticals Inc. (TSE:MDP) Lowered by AnalystMedexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Research analysts at Bloom Burton dropped their Q3 2025 earnings per share (EPS) estimates for shares of Medexus Pharmaceuticals in a research note issued to investors on Friday, August 9th. Bloom Burton analyst D. Martin now expects that theAugust 12, 2024 | marketbeat.comMedexus Pharmaceuticals Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen NextAugust 10, 2024 | finance.yahoo.comMedexus Pharmaceuticals (MDP) Scheduled to Post Earnings on WednesdayMedexus Pharmaceuticals (TSE:MDP) will be releasing earnings after the market closes on Wednesday, August 7, Zacks reports.July 31, 2024 | marketbeat.comMedexus Pharmaceuticals Inc (MDP)May 24, 2024 | investing.comWith A Return On Equity Of 20%, Has Medexus Pharmaceuticals Inc.'s (TSE:MDP) Management Done Well?May 8, 2024 | finance.yahoo.comMedexus Pharmaceuticals Inc (P731.BE)February 13, 2024 | au.finance.yahoo.comMedexus Pharmaceuticals Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen NextFebruary 10, 2024 | finance.yahoo.comMedexus Schedules Third Fiscal Quarter 2024 Conference CallJanuary 30, 2024 | finance.yahoo.comBoasting A 23% Return On Equity, Is Medexus Pharmaceuticals Inc. (TSE:MDP) A Top Quality Stock?November 30, 2023 | finance.yahoo.comMedexus Announces Strong Fiscal Q2 2024 Results, Including Quarterly Revenue of US$30.3 MillionNovember 8, 2023 | finance.yahoo.comMedexus Schedules Second Fiscal Quarter 2024 Conference CallNovember 1, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - MDP.DBOctober 16, 2023 | finance.yahoo.comMedexus Pharmaceuticals' (TSE:MDP) earnings growth rate lags the 131% return delivered to shareholdersOctober 11, 2023 | finance.yahoo.comMedexus Announces Closing of C$10 Million Bought-Deal Public OfferingOctober 6, 2023 | finance.yahoo.comShareholders May Be More Conservative With Medexus Pharmaceuticals Inc.'s (TSE:MDP) CEO Compensation For NowSeptember 15, 2023 | finance.yahoo.comMedexus Pharmaceuticals (MEDXF) Price Target Increased by 16.36% to 3.18August 31, 2023 | msn.comClosing Bell: Medexus Pharmaceuticals Inc up on Wednesday (MDP)August 23, 2023 | theglobeandmail.comHere's Why We Think Medexus Pharmaceuticals (TSE:MDP) Is Well Worth WatchingAugust 19, 2023 | finance.yahoo.comMedexus Pharmaceuticals Inc (MDP) Gets a Buy Rating from Stifel NicolausJuly 13, 2023 | markets.businessinsider.comMedexus Pharmaceuticals Inc (MDP) Receives a Buy from Echelon Wealth PartnersJune 22, 2023 | markets.businessinsider.comMedexus Pharmaceuticals Inc.: Medexus Generates Record Revenue of Us$108.1 Million in Fiscal Year 2023June 21, 2023 | finanznachrichten.deMedexus Generates Record Revenue of US$108.1 Million in Fiscal Year 2023June 21, 2023 | finance.yahoo.comMedexus Highlights Data on Trecondyv (Treosulfan) Presented at MDS 2023June 13, 2023 | finance.yahoo.comMedexus Demonstrates Cost-Effectiveness of Gleolan-Guided Surgery for High-Grade GliomaMay 9, 2023 | finance.yahoo.comClosing Bell: Medexus Pharmaceuticals Inc down on Tuesday (MDP)May 3, 2023 | theglobeandmail.comMedexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor ConferenceApril 18, 2023 | finance.yahoo.comClosing Bell: Medexus Pharmaceuticals Inc down on Thursday (MDP)April 14, 2023 | theglobeandmail.comClosing Bell: Medexus Pharmaceuticals Inc down on Wednesday (MDP)April 13, 2023 | theglobeandmail.comClosing Bell: Medexus Pharmaceuticals Inc up on Tuesday (MDP)April 12, 2023 | theglobeandmail.comClosing Bell: Medexus Pharmaceuticals Inc up on Thursday (MDP)April 7, 2023 | theglobeandmail.comClosing Bell: Medexus Pharmaceuticals Inc WT flat on Thursday (MDP-WT)April 7, 2023 | theglobeandmail.comClosing Bell: Medexus Pharmaceuticals Inc up on Friday (MDP)April 2, 2023 | theglobeandmail.comMedexus Announces US$58.5 million in New Credit FacilitiesMarch 8, 2023 | finance.yahoo.comMedexus Announces US$58.5 million in New Credit FacilitiesMarch 8, 2023 | finance.yahoo.comIIROC Trading Halt - MDP.WTFebruary 23, 2023 | finance.yahoo.comMedexus Welcomes Two New Board MembersFebruary 6, 2023 | finance.yahoo.comMedexus Schedules Third Fiscal Quarter 2023 Conference CallJanuary 31, 2023 | finance.yahoo.comMedexus Schedules First Quarter 2023 Conference CallAugust 2, 2022 | finance.yahoo.comTreosulfan NDA Resubmitted to FDAJuly 25, 2022 | finance.yahoo.comTreosulfan Pivotal Study Results PublishedJune 6, 2022 | finance.yahoo.comMedexus Pharmaceuticals Provides Update on Resubmission of Treosulfan NDAMay 24, 2022 | finance.yahoo.com Get Medexus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDP and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto Crash Ahead? (27 Experts Weigh In) (Ad)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you! Click here to reserve your spot at the emergency crypto summit now. MDP Media Mentions By Week MDP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDP News Sentiment▼0.000.41▲Average Medical News Sentiment MDP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDP Articles This Week▼10▲MDP Articles Average Week Get Medexus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cardiol Therapeutics News Today BioSyent News Today HLS Therapeutics News Today MediPharm Labs News Today Charlotte's Web News Today Decibel Cannabis News Today Willow Biosciences News Today Crescita Therapeutics News Today Medicure News Today Indiva News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:MDP) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medexus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
